Krilogy Financial
KURA icon

Krilogy Financial’s Kura Oncology KURA Stock Holding History

Krilogy Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-10,509
Closed -$115K – 1140
2026
Q2 		$115K Buy
+10,509
New +$99.2K ﹤0.01% 1001
2026
Q1 		– Sell
-11,715
Closed -$100K – 1022
2025
Q4 		$100K Sell
11,715
-2,472
-17% -$25.9K ﹤0.01% 902
2025
Q3 		$141K Buy
+14,187
New +$101K 0.01% 837

Other funds holding KURA

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Flower City Capital
Flower City Capital Pittsford, New York $234M AUM 15.69% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
Sanders Morris Harris
Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

Krilogy Financial's KURA Position: Q3 2026 in Review

Krilogy Financial sold out of Kura Oncology (KURA) in Q3 2026, closing a stake of 10,509 shares — an estimated $115K sold.

Krilogy Financial first reported a position in KURA in Q3 2025 and held it in 3 quarters. The position peaked at $141K in Q3 2025. 28 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • Krilogy Financial reported no remaining Kura Oncology position as of Q3 2026 after selling out during the quarter.
  • Krilogy Financial sold 10,509 Kura Oncology shares in Q3 2026, an estimated $115K.
  • Krilogy Financial first reported a position in Kura Oncology in Q3 2025 and held it in 3 quarters.
  • Krilogy Financial's Kura Oncology position peaked at $141K in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.